X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4090) 4090
Book Review (315) 315
Publication (312) 312
Conference Proceeding (23) 23
Book Chapter (7) 7
Dissertation (4) 4
Magazine Article (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
overall survival (3776) 3776
index medicus (2569) 2569
humans (2213) 2213
oncology (2181) 2181
female (1796) 1796
middle aged (1621) 1621
prognosis (1541) 1541
male (1491) 1491
aged (1432) 1432
cancer (1276) 1276
adult (1164) 1164
survival (1075) 1075
chemotherapy (1005) 1005
disease-free survival (986) 986
retrospective studies (789) 789
care and treatment (731) 731
analysis (730) 730
metastasis (717) 717
aged, 80 and over (712) 712
surgery (709) 709
treatment outcome (708) 708
survival analysis (630) 630
medical prognosis (600) 600
patient outcomes (595) 595
progression-free survival (566) 566
neoplasm staging (554) 554
survival rate (508) 508
research (501) 501
kaplan-meier estimate (488) 488
tumors (468) 468
patients (460) 460
carcinoma (447) 447
medicine & public health (425) 425
multivariate analysis (398) 398
proportional hazards models (388) 388
radiotherapy (384) 384
breast cancer (361) 361
young adult (354) 354
therapy (352) 352
hematology (344) 344
health aspects (342) 342
expression (338) 338
risk factors (336) 336
development and progression (306) 306
follow-up studies (306) 306
antineoplastic combined chemotherapy protocols - therapeutic use (303) 303
cancer therapies (291) 291
recurrence (278) 278
adolescent (277) 277
hematology, oncology and palliative medicine (275) 275
medical research (265) 265
studies (264) 264
diagnosis (251) 251
mortality (247) 247
lung cancer (241) 241
meta-analysis (237) 237
medicine, experimental (233) 233
colorectal cancer (231) 231
cancer patients (226) 226
gene expression (225) 225
antineoplastic agents - therapeutic use (222) 222
hepatocellular carcinoma (217) 217
management (217) 217
biomarkers (214) 214
trial (208) 208
adenocarcinoma (203) 203
neoplasms. tumors. oncology. including cancer and carcinogens (202) 202
risk (202) 202
original (201) 201
clinical trials (198) 198
radiation therapy (198) 198
time factors (198) 198
cell biology (195) 195
genetic aspects (194) 194
immunohistochemistry (193) 193
cancer research (192) 192
outcomes (190) 190
disease progression (188) 188
original research (188) 188
oncology, experimental (183) 183
age (181) 181
abridged index medicus (176) 176
prognostic-factors (176) 176
metastases (173) 173
gastroenterology & hepatology (170) 170
progression (168) 168
research paper (167) 167
breast-cancer (166) 166
cohort studies (160) 160
usage (159) 159
liver cancer (154) 154
medicine, research & experimental (152) 152
ovarian cancer (152) 152
neoplasm metastasis (150) 150
clinical neurology (147) 147
epidemiology (147) 147
resection (147) 147
combined modality therapy (146) 146
radiology, nuclear medicine & medical imaging (146) 146
cells (144) 144
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4033) 4033
Russian (20) 20
Korean (19) 19
German (13) 13
Chinese (7) 7
Spanish (7) 7
French (3) 3
Japanese (3) 3
Polish (3) 3
Portuguese (3) 3
Italian (2) 2
Croatian (1) 1
Hungarian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S887 - S888
Conference Proceeding
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S336 - S337
Conference Proceeding
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2019, Volume 174, Issue 2, pp. 443 - 452
Journal Article
Journal of Cancer, ISSN 1837-9664, 2019, Volume 10, Issue 2, pp. 418 - 429
Objective: Capecitabine is an antimetabolic fluoropyrimidine deoxynucleoside carbamate drug that can be converted to 5-FU in vivo. Currently, the role of... 
Overall survival (OS) | Breast cancer | Disease-free survival (DFS) | Capecitabine | TRIAL | capecitabine | THERAPY | ONCOLOGY | disease-free survival (DFS) | ADJUVANT CAPECITABINE | breast cancer | COMBINATION | DOCETAXEL | overall survival (OS)
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 63, pp. 107125 - 107133
Circular RNAs (circRNAs) in the peripheral blood have been reported to be associated with cancer. However, there are few studies about circRNAs in intracranial... 
Overall survival (OS) | Disease-free survival (DFS) | Diagnosis | Circular RNAs (circRNAs) | Intracranial aneurysms (IA) | intracranial aneurysms (IA) | ABUNDANT | BIOGENESIS | disease-free survival (DFS) | diagnosis | circular RNAs (circRNAs) | overall survival (OS) | CELL BIOLOGY
Journal Article
Neoplasma, ISSN 0028-2685, 03/2019, Volume 66, Issue 2, pp. 301 - 307
A score model based on clinical characteristics in advanced hepatocellular carcinoma (HCC) patients treated with systemic chemotherapy of... 
ADVANCED HEPATOCELLULAR-CARCINOMA | oxaliplatin-containing regimen | score model | MULTICENTER | HCC patients | TUMOR RESPONSE | OPEN-LABEL | SORAFENIB | GEMCITABINE | overall survival (OS) | THERAPY | ONCOLOGY | SYSTEMIC CHEMOTHERAPY | progression-free survival (PFS)
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 04/2019, Volume 120, Issue 4, pp. 6057 - 6070
Journal Article
Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 15, pp. 2955 - 2964
The average tumor volume doubling time (midDT) of lung metastases from follicular cell‐derived thyroid cancer is an accessible, easily calculated, and reliable... 
lung metastasis | metastatic thyroid cancer | multikinase inhibitor (MKI) therapy | structural doubling time | overall survival (OS) | radioactive iodine‐refractory thyroid cancer | radioactive iodine-refractory thyroid cancer | PROGNOSTIC IMPACT | GROWTH-RATES | CANCER | CALCITONIN | ONCOLOGY | RECURRENCE | PAPILLARY | DISTANT METASTASES | Lung Neoplasms - drug therapy | Adenocarcinoma, Follicular - pathology | Thyroglobulin - metabolism | Humans | Lung Neoplasms - metabolism | Middle Aged | Lung Neoplasms - pathology | Male | Survival Rate | Tumor Burden | Young Adult | Lung Neoplasms - secondary | Protein Kinase Inhibitors - therapeutic use | Adenocarcinoma, Follicular - secondary | Adenocarcinoma, Follicular - drug therapy | Adolescent | Aged, 80 and over | Adult | Female | Adenocarcinoma, Follicular - metabolism | Aged | Retrospective Studies | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Cancer patients | Care and treatment | Thyroid cancer | Diagnosis | Research | Health aspects | Tumors | Correlation coefficient | Therapy | Growth rate | Lung | Lung cancer | Correlation coefficients | Metastasis | Patients | Survival | Metastases | Thyroid carcinoma | Inhibitors | Thyroglobulin | Mathematical analysis | Pulmonary lesions | Health risk assessment | Iodine | Cancer | Thyroid | Index Medicus | Abridged Index Medicus
Journal Article
WIENER KLINISCHE WOCHENSCHRIFT, ISSN 0043-5325, 11/2018, Volume 130, Issue 21-22, pp. 659 - 664
ObjectiveTo analyze drug adherence, overall survival (OS) and hospitalization rates of patients with castration-resistant prostate cancer (CRPC) treated with... 
Medication adherence | BREAST-CANCER | WOMEN | MEDICINE, GENERAL & INTERNAL | Abiraterone acetat (AA) | PREDNISONE | Enzalutamide (ENZ) | PREDICTORS | Castration-resistant prostate cancer (CRPC) | Overall survival (OS) | PATTERNS | CHEMOTHERAPY
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 08/2019, Volume 45, Issue 8, pp. 1468 - 1478
Cholangiocellular carcinoma (CCA) is an aggressive malignancy with a dismal prognosis. Among curative treatment options for CCA, radical surgical resection... 
Cholangiocarcinoma (CCA) | Overall survival (OS) | Lymphovascular invasion (LVI) | Disease-free survival (DFS) | CANCER PATIENTS | SURVIVAL | SURGERY | RISK-FACTORS | MANAGEMENT | PERINEURAL INVASION | CHEMOTHERAPY | POSITRON-EMISSION-TOMOGRAPHY | THERAPY | ONCOLOGY | RECURRENCE | SURGICAL RESECTION | Analysis | Metastasis | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 69, pp. 113977 - 113986
The expression level and clinical significance of NR4A1 are presently unknown in the non-small-cell lung carcinoma (NSCLC). This study aimed to explore the... 
Progression free survival (PFS) | Recurrence | Overall survival (OS) | Prognosis | Non-small-cell lung carcinoma (NSCLC) | non-small-cell lung carcinoma (NSCLC) | recurrence | CANCER-CELLS | progression free survival (PFS) | ORPHAN NUCLEAR RECEPTORS | prognosis | POTENTIAL ROLE | CHEMOTHERAPY | overall survival (OS) | CELL BIOLOGY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.